Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication

by Mei Wang, Meihong Wu, Minglu Liu, Zhengqing Yan, Dongliang Mao
Published 2020-06-01

Spatiotemporal control of cell–cell reversible interactions using molecular engineering

by Peng Shi, Enguo Ju, Zhengqing Yan, Nan Gao, Jiasi Wang, Jianwen Hou, Yan Zhang, Jinsong Ren, Xiaogang Qu
Published 2016-10-01

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades

by Xiaoyan Wang, Bingchen Wu, Zhengqing Yan, Guoqiang Wang, Shiqing Chen, Jian Zeng, Feng Tao, Bichun Xu, Honggang Ke, Mei Li
Published 2021-05-01